Credit Suisse’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-11,282
Closed -$208K – 4340
2017
Q3
$208K Buy
+11,282
New +$195K ﹤0.01% 3916
2015
Q4
– Sell
-11,656
Closed -$210K – 4464
2015
Q3
$210K Buy
+11,656
New +$260K ﹤0.01% 3906

Other funds holding ENTL

Credit Suisse's ENTL Position: Q4 2017 in Review

Credit Suisse sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 11,282 shares — an estimated $208K sold.

Credit Suisse first reported a position in ENTL in Q3 2015 and held it in 2 quarters. The position peaked at $210K in Q3 2015. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Credit Suisse reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Credit Suisse sold 11,282 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $208K.
  • Credit Suisse first reported a position in Entellus Medical, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • Credit Suisse's Entellus Medical, Inc. Common Stock position peaked at $210K in Q3 2015.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.